Primary record
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol; sulfuric acid
- 库存
- 1,018 克
- 纯度
- 99.0 %
- CAS
- 49842-07-1
化合物标识与属性
- CAS
- 49842-07-1
- PubChem CID
- 62005
- SMILES
- C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N.OS(=O)(=O)O
- Canonical SMILES
- NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O.O=S(=O)(O)O
名称与同义词
- TOBRAMYCIN SULFATE
- Tobramycin sulphate
- Distobram
- Nebcin
- Gernebcin
- Nebicina
- Obracine
- Tenemicin
- Tobra
- Tobi
- Dartobcin
- Tobraneg
- Tobrasix
- Nebcine
- Obracin
- Tobryne
- Tomycin
- Trazil
- Dicon
- Mixture Name
- Tobra Gobens
- 1-Epitobramycin sulfate
- T-Pred
- TOBRAMYCINSULFATE
- Tobramycin (sulfate)
- Tobramycin Impurity 4
- Tobramycin sulfate salt
- UNII-HJT0RXD7JK
- Tobramycin sulfate [USAN]
- Tobramycin Sulphate Salt
- Opera_ID_1050
- 49842-07-1
- Tobramycin sulfate [USP]
- Tobramycin (pharmacy bulk)
- AC1L1WB7
- MLS000069826
- SCHEMBL2837
- C18H39N5O13S
- ZEUUPKVZFKBXPW-TWDWGCDDSA-N
- CHEMBL1200780
- CTK8G3501
- EINECS 256-499-2
- MFCD00133864
- HMS2230J04
- CID62005
- EBC-98152
- KM1982
- SMR000058891
- 79645-27-5
- AKOS025310614
- C18H37N5O9.5/2H2O4S
- AN-41518
- BC655154
- K412
- LS-146941
- B4958
- NS00089156
- ST24050180
- C18-H37-N5-O9.5/2H2-O4-S
- 842T071
- Tobramycin sulfate salt, aminoglycoside antibiotic
- Nebramycin Factor 6 (sulfate);Deoxykanamycin B (sulfate)
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid
- (2S,3R,4S,5S,6R)-4-Amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol Sulfate
- 126777-32-0
- 2-ETHOXY-5-[(MORPHOLINE-4-CARBONYL)-AMINO]-BENZENESULFONYLCHLORIDE
- TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol; sulfuric acid
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol;sulfuric acid
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol; sulfuric acid
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-, sulfate (2:5) (salt)
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-, sulfate (salt)
- D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy-, sulfate (salt)
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-, sulfate (2:5)(salt)
- Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-, D-, sulfate (salt)
- Tobramycin Sulfate Salt; O-3-amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-a-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-D-streptamine Sulfate (5:2)